Since Brexit, the UK has been subject to two separate regulatory frameworks on medical devices. Great Britain is subject to the Medical...

This article discusses the first CRISPR therapy seeks regulatory approval, raising the question but will it be able to avoid the pitfalls...

Alex Denoon, Chris Bates and Jamie Hatzel discuss the UK government's proposed statutory regime

Philip Ball writes on an important contribution to the discussion on the twilit zone between human embryo models and actual human...

The UK government recently released a draft copy of a statutory instrument which will introduce new post-market surveillance (PMS) rules...

The Department of Health and Social Care (DHSC) recently announced a consultation for a review of the statutory scheme for branded...

The MHRA has appointed two new UK Approved Bodies for medical devices, namely the UK affiliates of EU Notified Bodies TÜV Rheinland and...

The UK government recently released the text of a new draft statutory instrument (SI) which will update the post-market surveillance...

European Commission proposes to ease the regulatory burden for gene-edited plants. But when will it become law, and in what form? The...

"Synthetic Embryos" are neither Synthetic nor Embryos. So why are editors giving that name to stem cell-based models of human...

This week a project was launched to develop the first governance framework for research involving stem cell-based embryo models (SCBEMs)...